# The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy

> **NCT01450813** · NA · COMPLETED · sponsor: **Medtronic - MITG** · enrollment: 80 (actual)

## Conditions studied

- Anesthesia
- Neuromuscular Blockade

## Interventions

- **DRUG:** Saline 0.06 ml/kg
- **DRUG:** Rocuronium 0.2 mg/kg
- **DRUG:** Rocuronium 0.4 mg/kg
- **DRUG:** Rocuronium 0.6 mg/kg

## Key facts

- **NCT ID:** NCT01450813
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01450813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01450813, "The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01450813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*